MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial

• Grégoire Le Gal,
• Sam Schulman,
• Jean Philippe Galanaud,
• Jameel Abdulrehman,
• A Lazo-Langner,
• Sudeep Shivakumar,
• Susan Kahn

Affiliations

Grégoire Le Gal

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Sam Schulman

Medicine, McMaster University, Hamilton, Ontario, Canada

Jean Philippe Galanaud

Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Jameel Abdulrehman

Medicine, University Health Network, Toronto, Ontario, Canada

A Lazo-Langner

Medicine, Western University, London, Ontario, Canada

Sudeep Shivakumar

Medicine, Dalhousie University, Halifax, Nova Scotia, Canada

Susan Kahn

Medicine, McGill University, Montreal, Quebec, Canada